This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Mechanism of Action of High-Dose IL-2 (Aldesleukin...
Clinical trial

Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer

Read time: 1 mins
Last updated:16th Mar 2006
To better understand how IL-2 causes tumors to shrink.
Category Value
Study start date 2006-03-16

View full details